Patrick Pierre Michel

18PUBLICATIONS
32CO-AUTHORS
Nanotoxicology, health and safetyGenetically modified animalsOptical technologyMedical infection agents (incl. prions)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 29, 2025
Uric Acid, the End-Product of Purine Metabolism, Mitigates Tau-Related Abnormalities: Comparison with DOT, a Non-Antibiotic Oxytetracycline Derivative.

Bianca Andretto de Mattos, Rodrigo Hernán Tomas-Grau, Thaís Antonia Alves Fernandes

|Jul 24, 2025
Protein Coaggregation in Caribbean Atypical Parkinsonism: The Contribution of Annonacin.

Florencia González-Lizárraga, Susana Boluda, José Ruiz Hidalgo

|Mar 22, 2025
Oxytetracycline and its Non-Antibiotic Derivative DOT Protect Midbrain Dopamine Neurons from Iron-Driven Oxidative Damage.

Thaís Antonia Alves Fernandes, Aurore Tourville, Ismaila Ciss

|Mar 25, 2024
C9-Functionalized Doxycycline Analogs as Drug Candidates to Prevent Pathological α-Synuclein Aggregation and Neuroinflammation in Parkinson's Disease Degeneration.

Clémence Rose, Rodrigo Hernán Tomas-Grau, Brenda Zabala

|Nov 28, 2023
The two synthetic cannabinoid compounds 4'-F-CBD and HU-910 efficiently restrain inflammatory responses of brain microglia and astrocytes.

Maurício Dos Santos Pereira, Bruna Maitan Santos, Rocio Gimenez

|Oct 18, 2023
The specific NQO2 inhibitor, S29434, only marginally improves the survival of dopamine neurons in MPTP-intoxicated mice.

Maeva Vallucci, Jean A Boutin, Elzbieta Janda

Pageof 3

Frequent Collaborators

5 joint publications

Jean-Michel Brunel

5 joint publications

Laurent Ferrié

4 joint publications

Rodrigo Tomas-Grau

4 joint publications

Bruno Figadère